Paid Clinical Trials Tennessee
Discover 1,848 paid clinical trials in Tennessee. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Observational StudyPhysiological Brain Atlas Development
Sponsor:
Vanderbilt University Medical Center
Location:
Code:
NCT00575081
Conditions
Parkinson's Disease
Obsessive Compulsive Disorder
Dystonia
Essential Tremor
Epilepsy
Eligibility Criteria
Sex: All
Age: 6 - 70+
Healthy Volunteers: Not accepted
Interventions
Stereotactic brain procedures
Observational StudyRegistry of Avance® Nerve Graft's Utilization and Recovery Outcomes Post Peripheral Nerve Reconstruction
Sponsor:
Axogen Corporation
Location:
Code:
NCT01526681
Conditions
Peripheral Nerve Injuries
Eligibility Criteria
Sex: All
Age: 0 - 70+
Healthy Volunteers: Not accepted
Interventions
Processed Human Nerve Graft
Standard Treatment, Autogenous Nerve Graft, Direct Suture, etc.
Autogenous Nerve Graft
Nerve Tube Conduit
Autologous Breast Reconstruction with Neurotization
Neurophysiology BiomarkersNeurophysiology Biomarkers of Cognitive Impairment Associated with Deep Brain Stimulation
Sponsor:
Vanderbilt University Medical Center
Location:
Code:
NCT05933681
Conditions
Parkinson Disease
Eligibility Criteria
Sex: All
Age: 40+
Healthy Volunteers: Not accepted
Interventions
Neural recordings and stimulation
Remibrutinib vs. TeriflunomideEfficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)
Sponsor:
Novartis Pharmaceuticals
Location:
Code:
NCT05156281
Conditions
Relapsing Multiple Sclerosis
Eligibility Criteria
Sex: All
Age: 18 - 55
Healthy Volunteers: Not accepted
Interventions
Remibrutinib
Teriflunomide
BT8009Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies
Sponsor:
BicycleTx Limited
Location:
Code:
NCT04561362
Conditions
Urinary Bladder Neoplasm
Triple Negative Breast Neoplasms
Hormone Receptor Positive, HER2-negative Neoplasms
Hormone Receptor Positive, HER2-low Neoplasms
Breast Neoplasms
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
BT8009
Pembrolizumab
BupivacainePostoperative Pain Control With Lipossomic Extended Release Bupivacaine
Sponsor:
University of Tennessee
Location:
Code:
NCT03560362
Conditions
Pain, Postoperative
Lung Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Bupivacaine liposome
Bupivacaine / Epinephrine
Nexel Total ElbowClinical Outcomes Study of the Nexel Total Elbow
Sponsor:
Zimmer Biomet
Location:
Code:
NCT02469662
Conditions
Elbow Joint Destruction
Post-traumatic Lesions
Ankylosed Joints
Advanced Rheumatoid Arthritis
Joint Instability or Loss of Motion
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Nexel Total Elbow
P-CD19CD20-ALLO1P-CD19CD20-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With B Cell Malignancies
Sponsor:
Poseida Therapeutics, Inc.
Location:
Code:
NCT06014762
Conditions
Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
High-grade B-cell Lymphoma
Primary Mediastinal Large B-cell Lymphoma (PMBCL)
Transformed Follicular Lymphoma (tFL)
Follicular Lymphoma Grade 3B
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
P-CD19CD20-ALLO1
Rimiducid
Observational StudyText-messaging Intervention to Support Parents After Their Child's Psychiatric Emergency
Sponsor:
Vanderbilt University Medical Center
Location:
Code:
NCT06456762
Conditions
Parents
Self Efficacy
Mental Health Literacy
Psychiatric Emergency
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
iPEACE: Intervention for Parent Education about Care after the ED
Text Messaging Reminders Only
LY3556050A Study of LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain
Sponsor:
Eli Lilly and Company
Location:
Code:
NCT06074562
Conditions
Diabetic Peripheral Neuropathy
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
LY3556050
Placebo